Oppenheimer & Co. Inc. Acquires 11,698 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Oppenheimer & Co. Inc. boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 32.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,361 shares of the financial services provider’s stock after purchasing an additional 11,698 shares during the period. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $6,262,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $29,000. HHM Wealth Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the last quarter. Bradley & Co. Private Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $32,000. Ashton Thomas Securities LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $33,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 1.1 %

Shares of IBB opened at $137.03 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The stock has a fifty day moving average of $135.82 and a 200-day moving average of $140.68.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.